Genetic study reveals hidden chapter in human evolution
18 March 2025Modern humans descended from not one, but at least 2 ancestral populations that drifted apart and later reconnected, long before modern humans spread across the globe.
Modern humans descended from not one, but at least 2 ancestral populations that drifted apart and later reconnected, long before modern humans spread across the globe.
A Cambridge scientist has played a leading role in sequencing Ludwig van Beethoven’s genome, revealing clues to the composer’s health and family history.
DNA analysis of thousands of tumours from NHS patients has found a ‘treasure trove’ of clues about the causes of cancer, with genetic mutations providing a personal history of the damage and repair processes each patient has been through.
Since childhood Stephen Baker says he had a grim fascination with poo. He caught the bug for microbiology and spent 12 years in Vietnam researching bacteria that cause diarrhoea. Stephen thinks that antibiotic-resistant bacteria is likely to be humanity’s biggest killer in the future. But says that if we keep doing the science, we have hope.
Whole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests, shortening the ‘diagnostic odyssey’ that affected families experience, and providing huge opportunities for future research.
Professor Ian Goodfellow played a crucial role in helping to bring the Ebola epidemic in Sierra Leone to a close in 2014. His team's work helped inform technology used today in the majority of SARS-CoV-2 sequencing, which is keeping us safe in the current pandemic.
British duo Professor Shankar Balasubramanian and Professor David Klenerman have been awarded the Millennium Technology Prize for their development of revolutionary DNA sequencing techniques.
Professor Sharon Peacock explains the story behind the UK's world-leading SARS-CoV-2 genomics capability.
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections.
Cambridge-led study discovers new genetic causes of rare diseases, potentially leading to improved diagnosis and better patient care.